<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Mao Y</submitter><funding>Xianyang Science and Technology Planning Project</funding><pagination>e0332378</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12435719</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>20(9)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) is the most common and clinically significant complication of ERCP, with an incidence of 3.5-9.7% in general populations and up to 14.7% in high-risk groups, leading to considerable morbidity, mortality, and healthcare costs. Although numerous multivariable prediction models have been developed, their predictor sets, methodological rigor, and clinical applicability remain highly variable.&lt;h4>Method&lt;/h4>We conducted a PRISMA 2020-compliant systematic review and meta-analysis, prospectively registered in PROSPERO (CRD42024556967). Nine databases were searched to June 1, 2024, for studies developing or validating multivariable PEP risk prediction models. Data on study/model characteristics, predictors, a</pubmed_abstract><journal>PloS one</journal><pubmed_title>Risk prediction model for post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review and meta-analysis.</pubmed_title><pmcid>PMC12435719</pmcid><funding_grant_id>L2023-ZDYF-SF-055</funding_grant_id><pubmed_authors>Fan H</pubmed_authors><pubmed_authors>Ouyang X</pubmed_authors><pubmed_authors>Dong H</pubmed_authors><pubmed_authors>He W</pubmed_authors><pubmed_authors>Li E</pubmed_authors><pubmed_authors>Liu Q</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Zhang C</pubmed_authors><pubmed_authors>Mao Y</pubmed_authors><pubmed_authors>Qiu L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Risk prediction model for post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review and meta-analysis.</name><description>&lt;h4>Background&lt;/h4>Post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) is the most common and clinically significant complication of ERCP, with an incidence of 3.5-9.7% in general populations and up to 14.7% in high-risk groups, leading to considerable morbidity, mortality, and healthcare costs. Although numerous multivariable prediction models have been developed, their predictor sets, methodological rigor, and clinical applicability remain highly variable.&lt;h4>Method&lt;/h4>We conducted a PRISMA 2020-compliant systematic review and meta-analysis, prospectively registered in PROSPERO (CRD42024556967). Nine databases were searched to June 1, 2024, for studies developing or validating multivariable PEP risk prediction models. Data on study/model characteristics, predictors, a</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025</publication><modification>2026-06-01T14:06:31.11Z</modification><creation>2026-04-08T13:19:08.419Z</creation></dates><accession>S-EPMC12435719</accession><cross_references><pubmed>40953036</pubmed><doi>10.1371/journal.pone.0332378</doi></cross_references></HashMap>